| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACSL3
|
acyl-CoA synthetase long-chain family member 3
|
|
AGRN
|
agrin
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
APC
|
adenomatous polyposis coli
|
|
API5
|
apoptosis inhibitor 5
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARL6IP6
|
ADP-ribosylation factor-like 6 interacting protein 6
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ASCC1
|
activating signal cointegrator 1 complex subunit 1
|
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF1
|
activating transcription factor 1
|
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
|
ATM
|
ATM serine/threonine kinase
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCL7A
|
B-cell CLL/lymphoma 7A
|
|
BCL9
|
B-cell CLL/lymphoma 9
|
|
BCR
|
breakpoint cluster region
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD3
|
bromodomain containing 3
|
|
BRD4
|
bromodomain containing 4
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
CANT1
|
calcium activated nucleotidase 1
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CARS
|
cysteinyl-tRNA synthetase
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase
|
|
CCNA1
|
cyclin A1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CHCHD7
|
coiled-coil-helix-coiled-coil-helix domain containing 7
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHIC2
|
cysteine-rich hydrophobic domain 2
|
|
CHN1
|
chimerin 1
|
|
CIC
|
capicua transcriptional repressor
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
|
CLTCL1
|
clathrin, heavy chain-like 1
|
|
COCH
|
cochlin
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COX6C
|
cytochrome c oxidase subunit VIc
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3L2
|
cAMP responsive element binding protein 3-like 2
|
|
CREBBP
|
CREB binding protein
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRTC3
|
CREB regulated transcription coactivator 3
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX10
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 10
|
|
DDX23
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 23
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6
|
|
DEK
|
DEK proto-oncogene
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIXDC1
|
DIX domain containing 1
|
|
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4A2
|
eukaryotic translation initiation factor 4A2
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
ELK4
|
ELK4, ETS-domain protein (SRF accessory protein 1)
|
|
ELL
|
elongation factor RNA polymerase II
|
|
ELN
|
elastin
|
|
EP300
|
E1A binding protein p300
|
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ETV1
|
ets variant 1
|
|
ETV4
|
ets variant 4
|
|
ETV5
|
ets variant 5
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCE
|
Fanconi anemia, complementation group E
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FANCG
|
Fanconi anemia, complementation group G
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FEV
|
FEV (ETS oncogene family)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR1OP
|
FGFR1 oncogene partner
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FH
|
fumarate hydratase
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXL2
|
forkhead box L2
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FUS
|
FUS RNA binding protein
|
|
GAS7
|
growth arrest-specific 7
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GLT1D1
|
glycosyltransferase 1 domain containing 1
|
|
GMPS
|
guanine monphosphate synthase
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GOLGA5
|
golgin A5
|
|
GOPC
|
golgi-associated PDZ and coiled-coil motif containing
|
|
GPC3
|
glypican 3
|
|
GPHN
|
gephyrin
|
|
HERPUD1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HIST1H4I
|
histone cluster 1, H4i
|
|
HLF
|
hepatic leukemia factor
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HOOK3
|
hook microtubule-tethering protein 3
|
|
HOXA11
|
homeobox A11
|
|
HOXA13
|
homeobox A13
|
|
HOXA9
|
homeobox A9
|
|
HOXC11
|
homeobox C11
|
|
HOXC13
|
homeobox C13
|
|
HOXD11
|
homeobox D11
|
|
HOXD13
|
homeobox D13
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSPA1L
|
heat shock 70kDa protein 1-like
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL2
|
interleukin 2
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IQSEC3
|
IQ motif and Sec7 domain 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDM5C
|
lysine (K)-specific demethylase 5C
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA1549
|
KIAA1549
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KTN1
|
kinectin 1 (kinesin receptor)
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LHFP
|
lipoma HMGIC fusion partner
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MALT1
|
MALT1 paracaspase
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MDS2
|
myelodysplastic syndrome 2 translocation associated
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MLH1
|
mutL homolog 1
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
|
|
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSN
|
moesin
|
|
MTCP1
|
mature T-cell proliferation 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUTYH
|
mutY homolog
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NACA
|
nascent polypeptide-associated complex alpha subunit
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFIB
|
nuclear factor I/B
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NIN
|
ninein (GSK3B interacting protein)
|
|
NISCH
|
nischarin
|
|
NONO
|
non-POU domain containing, octamer-binding
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OMD
|
osteomodulin
|
|
P2RY8
|
purinergic receptor P2Y, G-protein coupled, 8
|
|
PAFAH1B2
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX7
|
paired box 7
|
|
PAX8
|
paired box 8
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCM1
|
pericentriolar material 1
|
|
PCSK7
|
proprotein convertase subtilisin/kexin type 7
|
|
PDE4DIP
|
phosphodiesterase 4D interacting protein
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PER1
|
period circadian clock 1
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PML
|
promyelocytic leukemia
|
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha
|
|
PRCC
|
papillary renal cell carcinoma (translocation-associated)
|
|
PRDM16
|
PR domain containing 16
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PSMC5
|
proteasome (prosome, macropain) 26S subunit, ATPase, 5
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
RAD51B
|
RAD51 paralog B
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RANBP17
|
RAN binding protein 17
|
|
RAP1GDS1
|
RAP1, GTP-GDP dissociation stimulator 1
|
|
RAP2A
|
RAP2A, member of RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RB1
|
retinoblastoma 1
|
|
RBM15
|
RNA binding motif protein 15
|
|
RECQL4
|
RecQ protein-like 4
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RET
|
ret proto-oncogene
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPL22
|
ribosomal protein L22
|
|
RPN1
|
ribophorin I
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
SLC24A3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3
|
|
SLC25A15
|
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15
|
|
SLC25A18
|
solute carrier family 25 (glutamate carrier), member 18
|
|
SLC45A3
|
solute carrier family 45, member 3
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SPARCL1
|
SPARC-like 1 (hevin)
|
|
SRGAP3
|
SLIT-ROBO Rho GTPase activating protein 3
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
SSX4
|
synovial sarcoma, X breakpoint 4
|
|
STK11
|
serine/threonine kinase 11
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAL2
|
T-cell acute lymphocytic leukemia 2
|
|
TBX3
|
T-box 3
|
|
TCEA1
|
transcription elongation factor A (SII), 1
|
|
TCF12
|
transcription factor 12
|
|
TCF3
|
transcription factor 3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFEB
|
transcription factor EB
|
|
TFG
|
TRK-fused gene
|
|
TFRC
|
transferrin receptor
|
|
THRAP3
|
thyroid hormone receptor associated protein 3
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TP53
|
tumor protein p53
|
|
TPM3
|
tropomyosin 3
|
|
TPM4
|
tropomyosin 4
|
|
TPR
|
translocated promoter region, nuclear basket protein
|
|
TRIM27
|
tripartite motif containing 27
|
|
TRIP11
|
thyroid hormone receptor interactor 11
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTL
|
tubulin tyrosine ligase
|
|
UROS
|
uroporphyrinogen III synthase
|
|
USP6
|
ubiquitin specific peptidase 6
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VPS26B
|
vacuolar protein sorting 26 homolog B (S. pombe)
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WHSC1L1
|
Wolf-Hirschhorn syndrome candidate 1-like 1
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
ZNF331
|
zinc finger protein 331
|
|
ZNF384
|
zinc finger protein 384
|
|
ZNF521
|
zinc finger protein 521
|